BMI View: We have decided not to alter our near-term outlook for the Belarusian pharmaceutical market this quarter. We continue to regard factors such as local currency devaluation, state dominance in pharmaceutical manufacturing and regulatory bias against foreign producers as being instrumental in shaping the development of the country’s pharmaceutical market. While demographic and epidemiological factors are conducive to larger volume consumption of treatments targetting non-communicable diseases in particular, economic uncertainty and substantial out-of-pocket expenses will continue to hamper concerted gains in this direction.
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120545.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/belarus-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment